COVID-19: FDA Authorizes Pharmacists to Prescribe PAXLOVID with Certain Limits

 

COVID-19: FDA Authorizes Pharmacists to Prescribe PAXLOVID with Certain Limits

 

The FDA issued an emergency use authorization (EUA) for PAXLOVID (nirmatrelvir co-packaged with ritonavir) for the treatment of mild-to-moderate COVID-19 in certain adults and pediatric patients at high risk for progression to severe COVID-19, including hospitalization or death. On July 6, the FDA revised the EUA to let pharmacists prescribe and dispense PAXLOVID to eligible patients without seeing a doctor or other clinician.

More Information:

Facebook
Twitter
Email